Trevena Inc (TRVN)
2.085
+0.12
(+6.11%)
USD |
OTCM |
Nov 08, 15:39
Trevena Revenue (TTM): 0.443M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 0.443M |
March 31, 2024 | 3.139M |
December 31, 2023 | 3.125M |
September 30, 2023 | |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | 0.378M |
December 31, 2021 | 0.567M |
September 30, 2021 | 0.637M |
June 30, 2021 | 3.456M |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 |
Date | Value |
---|---|
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | 7.50M |
March 31, 2016 | 7.50M |
December 31, 2015 | 6.25M |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | 0.535M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.378M
Minimum
Mar 2022
3.456M
Maximum
Jun 2021
1.678M
Average
0.637M
Median
Sep 2021
Revenue (TTM) Benchmarks
Pfizer Inc | 59.37B |
United Therapeutics Corp | 2.756B |
Syndax Pharmaceuticals Inc | -- |
Arcus Biosciences Inc | 263.00M |
NovaBay Pharmaceuticals Inc | 12.02M |